ROBERT ROGGENSACK, OD
Optometrist in OSAGE, Iowa. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROBERT ROGGENSACK, OD filed 427 Medicare Part D claims in 2023 as a Optometrist in OSAGE, Iowa, prescribing 68% generic.
- 427
- Part D claims, 2023
- 68%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROBERT ROGGENSACK, OD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
427 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ROBERT ROGGENSACK, OD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Iowa
How Optometrist compares to other specialties among Iowa providers
Optometrist share within Iowa
Optometrist is one of the more visible NUCC categories in Iowa
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Optometrist ABMS/AOA estimate
Est. board-certified rate (Optometrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Optometrist US NPIs
Specialty board-certified rate — Optometrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROBERT ROGGENSACK, OD appears in the CMS NPPES registry as a Optometrist provider holding OD credentials at 620 N 8TH ST, OSAGE, IA, 50461, with a listed phone of (641) 723-6100. NPI 1891887410 was issued on 09/29/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROGGENSACK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 427 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $54K in drug spend, split 32% brand-name and 68% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1891887410 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 09/29/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROBERT ROGGENSACK, OD's current license status, disciplinary history, and board certifications with the Iowa Board of Medicine in Iowa before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Above average
32% brand-name claims vs 68% generic, on 427 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 702
- Total Day Supply
- 20,287
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $48K
- Generic Drug Cost
- $5K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 78.6 years
- Avg HCC Risk Score
- 0.92
- Gender Split
- 60% female / 40% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROBERT ROGGENSACK, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
132 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
72 claims
- Lumigan 47
Lumigan
47 claims
- Timolol Maleate 45
Timolol Maleate
45 claims
- Combigan 29
Combigan
29 claims
- Brimonidine Tartrate 23
Brimonidine Tartrate
23 claims
- Doxycycline Monohy… 16
Doxycycline Monohydrate
16 claims
- Dorzolamide Hcl 13
Dorzolamide Hcl
13 claims
| Drug | Claims |
|---|---|
| Latanoprost | 132 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 72 |
| Lumigan Bimatoprost | 47 |
| Timolol Maleate | 45 |
| Combigan Brimonidine Tartrate/Timolol | 29 |
| Brimonidine Tartrate | 23 |
| Doxycycline Monohydrate | 16 |
| Dorzolamide Hcl | 13 |
| Restasis Multidose Cyclosporine | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How ROBERT ROGGENSACK, OD fits within the Optometrist landscape nationally.
ROBERT ROGGENSACK, OD's 427 claims are above the specialty average of 257.
Nearby Optometrist Providers in Iowa
Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as ROGGENSACK.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Iowa
Frequently Asked Questions
What is ROBERT ROGGENSACK, OD's specialty? ▼
How much does ROBERT ROGGENSACK, OD prescribe under Medicare Part D? ▼
Where is ROBERT ROGGENSACK, OD located? ▼
What is ROBERT ROGGENSACK, OD's NPI number? ▼
Does ROBERT ROGGENSACK, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does ROBERT ROGGENSACK, OD prescribe most often? ▼
Does ROBERT ROGGENSACK, OD accept Medicare? ▼
How can I verify ROBERT ROGGENSACK, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology